Public disclosure of payments from pharmaceutical, medical device, biologic, and medical supply manufacturers to physicians and hospitals will begin under a final rule on the Physician Payments Sunshine Act (Sunshine Act) published by the Centers for Medicare & Medicaid Services (CMS). Applicable manufacturers and group purchasing organizations (GPOs) will need to begin collecting data on and … Continue Reading »